CHIARITO, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 1.235
EU - Europa 436
AS - Asia 301
AF - Africa 34
SA - Sud America 8
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.017
Nazione #
US - Stati Uniti d'America 1.230
FI - Finlandia 150
CN - Cina 139
IE - Irlanda 92
SG - Singapore 88
IT - Italia 56
DE - Germania 48
IN - India 40
SE - Svezia 34
NG - Nigeria 32
FR - Francia 15
NL - Olanda 12
TR - Turchia 9
TH - Thailandia 7
RU - Federazione Russa 6
GB - Regno Unito 5
JP - Giappone 5
TW - Taiwan 5
BE - Belgio 4
BR - Brasile 4
AT - Austria 3
CU - Cuba 3
CZ - Repubblica Ceca 3
PE - Perù 3
UA - Ucraina 3
CA - Canada 2
IR - Iran 2
RS - Serbia 2
UG - Uganda 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
CL - Cile 1
CY - Cipro 1
ES - Italia 1
HK - Hong Kong 1
ID - Indonesia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
Totale 2.017
Città #
Chandler 193
Helsinki 150
Shanghai 129
Boardman 111
Wilmington 106
Dublin 92
New York 79
Singapore 62
Ashburn 54
San Mateo 50
Pune 37
Benin City 32
Los Angeles 29
Lawrence 22
Milan 22
Princeton 22
Ann Arbor 20
Leawood 16
Seattle 15
Fairfield 13
Woodbridge 13
Amsterdam 12
Paris 9
Kocaeli 7
Turin 7
Abbiategrasso 5
Falkenstein 5
Norwalk 5
Redmond 5
Santa Clara 5
Taipei 5
Brasília 4
Brussels 4
Moscow 4
Bangkok 3
Brno 3
Havana 3
Lima 3
Monza 3
Munich 3
Mykolayiv 3
Phoenix 3
Phuket 3
Brescia 2
Carbonara al Ticino 2
Ho Chi Minh City 2
Kampala 2
London 2
Lübeck 2
Milwaukee 2
Procida 2
Pulandian 2
San Diego 2
The Bronx 2
Toronto 2
Ankara 1
Belgrade 1
Bristol 1
Caloocan City 1
Chicago 1
Chisinau 1
Cicciano 1
Cowdenbeath 1
Cupertino 1
Gunzenhausen 1
Hangzhou 1
Henderson 1
Horn Lake 1
Hyderabad 1
Istanbul 1
Jakarta 1
Kashan 1
Kemerovo 1
Mladenovac 1
Nicosia 1
Perth 1
Pitesti 1
Redwood City 1
Rome 1
Sam Phran 1
San Severo 1
Sassari 1
Tappahannock 1
Tauranga 1
Trentola-Ducenta 1
Tübingen 1
Zhoukou 1
Totale 1.427
Nome #
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 62
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 61
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 60
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 59
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 56
Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation 54
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 50
The synergy stent in high-bleeding risk patients: why design matters 49
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry. 49
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? Interv Cardiol. 47
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study. 46
Safety and efficacy of polymer-free drug-eluting stents: Amphilimus-eluting Cre8 versus biolimus-eluting biofreedom stents 43
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights from the BEAT International Collaborative Registrys 42
Acute coronary syndrome in a patient with a residual aortic dissection flap after supracoronary aortic replacement: the role of intravascular ultrasound 40
Clinical challenges in an unusual setting: ST-elevation in a patient suffering from graft versus host disease, between thrombosis and coronary spasm 39
Mitral Valve Stenosis after Transcatheter Aortic Valve Replacement: Case Report and Review of the Literature 38
Left atrial appendage closure with the Ultraseal device: Initial experience and mid-term follow-up. 38
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials 38
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry 31
Characterization of Myocardial Injury in Patients With COVID-19 30
Antiplatelet therapy for secondary prevention of cardiovascular disease: challenging the certainties 29
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry) 28
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 25
Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel 25
Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 25
P2Y12 vs. aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and Meta-analysis 23
Direct oral anticoagulants versus Vitamin K antagonists in the treatment of left ventricular thrombosis: a systematic review and meta-analysis 23
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft 22
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey 22
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? 22
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention 21
Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials 21
A Complicated Case of Resistant Hypertension 21
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 20
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 20
Lower dose direct oral anticoagulants and improved survival: A combined analysis in patients with established atherosclerosis 20
Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents 19
Drug-eluting stents in diabetic patients: Are we still treading water? 19
The Cre8 amphilimus-eluting stent for the treatment of coronary artery disease: safety and efficacy profile 19
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 18
Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom 18
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 18
[Two-step strategy for the treatment of complex coronary artery disease and aortic stenosis in a patient with severely impaired left ventricular function] 17
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis 17
Long-term prognostic impact of subclinical myocardial dysfunction in patients recovered from COVID-19 17
Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside 17
Impact of complete revascularization on mortality in patients with ST-segment elevation myocardial infarction and multivessel disease: an updated meta-analysis 17
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 16
Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry) 16
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis 16
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 15
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 15
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 15
Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care? 15
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding 15
Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes 14
Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry 14
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 14
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 13
Postoperative Delirium in Individuals Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis 13
Prognostic value of tricuspid regurgitation 13
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 13
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial 13
Low-Dose Colchicine after Myocardial Infarction 12
Perioperative Management of P2Y12 Inhibitors in Patients Undergoing Cardiac Surgery within 1 Year of PCI 12
Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI 12
Predicting survival in patients with severe heart failure: risk scores validation in the HELP-HF cohort 12
Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold 12
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis 12
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent 11
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction 11
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy 11
Single or dual antiplatelet therapy after transcatheter aortic valve implantation. A meta-analysis of randomized controlled trials 11
One-year clinical outcome and predictors of ischemic and hemorrhagic events after percutaneous coronary intervention in elderly and very elderly patients 11
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 10
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI 10
Stepwise use of circulatory support devices in a patient refractory to cardiopulmonary resuscitation 10
Panta rhei, also drug eluting stent technology 9
Types of myocardial injury and mid-term outcomes in patients with COVID-19 9
Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization 9
Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry 9
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 9
Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis 9
A sex paradox in clinical outcomes following complex percutaneous coronary intervention 9
Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience 9
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 8
Long COVID-19 Cardiac Complications Are Associated With Autoimmunity to Cardiac Self-Antigens Sufficient to Cause Cardiac Dysfunction 8
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design 8
Transcatheter aortic valve replacement in patients with end-stage renal disease: Is "better than nothing" good enough? 7
Left main coronary artery disease: when and how to perform PCI? 7
Sex-Related Differences in the Prevalence and Prognostic Value of the Academic Research Consortium for High Bleeding Risk Criteria 7
Polymer-Free Biolimus-Eluting Stents or Polymer-Based Zotarolimus-Eluting Stents for Coronary Bifurcation Lesions 7
Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: A study-level meta-analysis 7
Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli The TAVI-SMALL Registry 7
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 6
Polymer-free biolimus-A9-eluting stent performance according to renal impairment: insights from the RUDI-FREE registry 6
Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis 6
Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial 6
Frailty according to the 2019 HFA‐ESC definition in patients at risk for advanced heart failure: Insights from the HELP‐HF registry 6
PROGNOSTIC VALUE OF HIGH-SENSITIVITY C-REATIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION 6
Totale 2.056
Categoria #
all - tutte 20.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.039


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021212 1 1 3 0 1 46 36 12 55 31 0 26
2021/2022137 5 2 5 28 3 1 4 23 11 8 34 13
2022/2023756 54 18 32 96 75 48 16 45 151 106 85 30
2023/2024917 89 84 169 76 34 110 56 58 20 51 78 92
2024/202566 32 5 29 0 0 0 0 0 0 0 0 0
Totale 2.088